PATENT CLAIM ANALYSIS

Application Number: 16226909
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["514", "019400"]

Abstract:
The present invention relates to compositions comprising improved flagellin derived constructs and methods of using the same in the treatment of various diseases.

Claim (Index 75):
A method of stimulating TLR5 signaling comprising administering to a subject in need thereof a composition comprising a polypeptide having an amino acid sequence that is about 95% sequence identical to SEQ ID NO: 35 or SEQ ID NO: 42.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15329870', '15500133', '15631427', '16014419', '13979104']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7528958921940849
- 35 USC 102 Novelty (BERT): 0.5971879957085486
- Combined Prediction Score: 0.7373251025455314
- Mean Citation Score: 329.936108
- Max Citation Score: 520.48157
- Similarity Product: 470.1247500205285

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test